Terumo Neuro (formerly MicroVention) announced today that it received FDA premarket approval (PMA) for its Carotid Stent ...

Applying ultrasound to help break up thrombus during carotid endarterectomy reduces adverse neurological outcomes in the first 30 days after surgery in patients with either symptomatic or asymptomatic ...

Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced that their Carotid Stent System has received Premarket Approval (PMA) ...

Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced that the company’s dual-layer micromesh carotid st ...

The most effective treatment for carotid artery stenosis is carotid endarterectomy (CEA). To date, randomized trials of this procedure versus best medical care have excluded patients aged 80 years ...

First Dual-Layer Micromesh Carotid Stent Approved for Use in the U.S. ALISO VIEJO, Calif., April 15, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly ...

Historically, aspirin has been the most commonly used adjunctive medication during CEA and is used to prevent thrombus formation both at the site and distally to the area of endarterectomy.

This week's topics include cell signatures in polycystic ovary syndrome (PCOS), a new technique for prostate biopsies, improving the safety of carotid endarterectomy, and long-term risk after a ...